Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Three Decades of Follow-up of Adults After Recovery From Invasive Pneumococcal Pneumonia.

Ajayi OO, Norton NB, Gress TW, Stanek RJ, Mufson MA.

Am J Med Sci. 2017 May;353(5):445-451. doi: 10.1016/j.amjms.2017.03.002. Epub 2017 Mar 6.

PMID:
28502330
2.

Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.

Berry AA, Abu-Elyazeed R, Diaz-Perez C, Mufson MA, Harrison CJ, Leonardi M, Twiggs JD, Peltier C, Grogg S, Carbayo A, Shapiro S, Povey M, Baccarini C, Innis BL, Henry O.

Hum Vaccin Immunother. 2017 Jul 3;13(7):1516-1522. doi: 10.1080/21645515.2017.1309486. Epub 2017 May 8.

3.

A 32-Year Study of the Effect of Pneumococcal Vaccines on Invasive Streptococcus pneumoniae Disease.

Stanek RJ, Norton NB, Mufson MA.

Am J Med Sci. 2016 Dec;352(6):563-573. doi: 10.1016/j.amjms.2016.09.002. Epub 2016 Sep 16.

PMID:
27916211
4.

Safety and Immunogenicity of Human Serum Albumin-Free MMR Vaccine in US Children Aged 12-15 Months.

Mufson MA, Diaz C, Leonardi M, Harrison CJ, Grogg S, Carbayo A, Carlo-Torres S, JeanFreau R, Quintero-Del-Rio A, Bautista G, Povey M, Da Costa C, Nicholson O, Innis BL.

J Pediatric Infect Dis Soc. 2015 Dec;4(4):339-48. doi: 10.1093/jpids/piu081. Epub 2014 Aug 7.

5.

Routine pneumococcal vaccination of children provokes new patterns of serotypes causing invasive pneumococcal disease in adults and children.

Norton NB, Stanek RJ, Mufson MA.

Am J Med Sci. 2013 Feb;345(2):112-20. doi: 10.1097/MAJ.0b013e3182517785.

PMID:
22814362
6.

Immunizations for adults and children.

Goebel LJ, Norton NB, Mufson MA.

W V Med J. 2012 May-Jun;108(3):22-8. No abstract available.

PMID:
22792652
7.

Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.

Blatter MM, Klein NP, Shepard JS, Leonardi M, Shapiro S, Schear M, Mufson MA, Martin JM, Varman M, Grogg S, London A, Cambron P, Douha M, Nicholson O, da Costa C, Innis BL.

Pediatr Infect Dis J. 2012 Aug;31(8):e133-40. doi: 10.1097/INF.0b013e318259fc8a.

PMID:
22622699
8.

Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease.

Mufson MA, Hao JB, Stanek RJ, Norton NB.

Am J Med Sci. 2012 Apr;343(4):303-9. doi: 10.1097/MAJ.0b013e31822d9860.

PMID:
21934596
9.

Barriers to vaccinating the elderly with H1N1 vaccine.

Brown JR, Goebel LJ, Neitch SM, Tweel HK, Mufson MA.

Am J Med Sci. 2011 Jul;342(1):24-6. doi: 10.1097/MAJ.0b013e31820e782b.

PMID:
21537156
10.

Emergence of a unique penicillin-resistant Streptococcus pneumoniae serogroup 35 strain.

Stanek RJ, Maher MB, Norton NB, Mufson MA.

J Clin Microbiol. 2011 Jan;49(1):400-4. doi: 10.1128/JCM.01620-10. Epub 2010 Oct 27.

11.

Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children.

Gomez M, Mufson MA, Dubovsky F, Knightly C, Zeng W, Losonsky G.

Pediatr Infect Dis J. 2009 Jul;28(7):655-8. doi: 10.1097/INF.0b013e318199c3b1.

PMID:
19483659
12.

Despite guidelines, some elderly people receive more than one dose of pneumococcal vaccine.

Goebel LJ, Mufson MA.

J Am Geriatr Soc. 2008 Sep;56(9):1760-1. doi: 10.1111/j.1532-5415.2008.01867.x. No abstract available.

PMID:
19166450
14.

Influenza season triggers pneumococcal vaccination.

Goebel LJ, Mufson MA.

J Am Geriatr Soc. 2006 Aug;54(8):1261-4.

PMID:
16913996
15.

Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia.

Dwyer R, Ortqvist A, Aufwerber E, Henriques Normark B, Marrie TJ, Mufson MA, Torres A, Woodhead MA, Alenius M, Kalin M.

Eur J Clin Microbiol Infect Dis. 2006 Aug;25(8):518-21.

PMID:
16896822
16.

Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia.

Mufson MA, Stanek RJ.

Clin Infect Dis. 2006 Jan 15;42(2):304-6. No abstract available.

PMID:
16355349
17.

Standing orders in an ambulatory setting increases influenza vaccine usage in older people.

Goebel LJ, Neitch SM, Mufson MA.

J Am Geriatr Soc. 2005 Jun;53(6):1008-10.

PMID:
15935025
19.
20.

Pneumococcal Pneumonia.

Mufson MA.

Curr Infect Dis Rep. 1999 Apr;1(1):57-64.

PMID:
11095768
21.

Surveillance of penicillin-resistant Streptococcus pneumoniae in one American metropolitan area, 1989-1998.

Sahloul RT, Stanek RJ, Mufson MA.

Eur J Clin Microbiol Infect Dis. 2000 Sep;19(9):704-7.

PMID:
11057505
22.

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries.

Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, Jorup C, Julander I, Marrie TJ, Mufson MA, Riquelme R, Thalme A, Torres A, Woodhead MA.

J Infect Dis. 2000 Sep;182(3):840-7. Epub 2000 Aug 17.

PMID:
10950779
23.

Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries.

Henriques B, Kalin M, Ortqvist A, Olsson Liljequist B, Almela M, Marrie TJ, Mufson MA, Torres A, Woodhead MA, Svenson SB, Källenius G.

J Infect Dis. 2000 Sep;182(3):833-9. Epub 2000 Aug 17.

PMID:
10950778
24.

Antibody response of pneumococcal vaccine: need for booster dosing?

Mufson MA.

Int J Antimicrob Agents. 2000 Mar;14(2):107-12.

PMID:
10720799
25.

The internal medicine clerkship: the view from the vantage point of one chair of medicine.

Mufson MA.

Am J Med. 1999 Aug;107(2):109-11. No abstract available.

PMID:
10460039
26.

A 20-year epidemiological study of pneumococcal meningitis.

Stanek RJ, Mufson MA.

Clin Infect Dis. 1999 Jun;28(6):1265-72.

PMID:
10451164
27.

Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997.

Mufson MA, Stanek RJ.

Am J Med. 1999 Jul 26;107(1A):34S-43S.

PMID:
10451007
28.

The internal medicine residency: curriculum change and workforce.

Mufson MA, Cooney TG.

Am J Med. 1998 Oct;105(4):259-61. No abstract available.

PMID:
9809684
29.
30.

Penicillin-resistant Streptococcus pneumoniae increasingly threatens the patient and challenges the physician.

Mufson MA.

Clin Infect Dis. 1998 Oct;27(4):771-3. No abstract available.

PMID:
9798032
31.

Professionalism in medicine: the department chair's perspective on medical students and residents.

Mufson MA.

Am J Med. 1997 Oct;103(4):253-5. No abstract available.

PMID:
9382114
32.

Phosphoprotein profile analysis of ruminant respiratory syncytial virus isolates.

Shadomy SV, Baker JC, Mufson MA, Velicer LL.

Am J Vet Res. 1997 May;58(5):478-81.

PMID:
9140554
33.

Identification of a variant subgroup A strain of respiratory syncytial virus.

Mufson MA, Stanek RJ.

J Clin Microbiol. 1996 Oct;34(10):2493-6.

34.
35.

Emergence of penicillin-resistant invasive pneumococci in a single American community.

Stanek RJ, Mufson MA.

Am J Med Sci. 1995 Oct;310(4):150-5.

PMID:
7573118
36.

Production and characterization of monoclonal antibodies to bovine respiratory syncytial virus.

Underwood WJ, McCallum Q, Velicer LF, Mufson MA, Baker JC.

Vet Microbiol. 1995 Feb;43(2-3):261-74.

PMID:
7740764
37.

Pneumococcal vaccine after 15 years of use. Another view.

Fedson DS, Shapiro ED, LaForce FM, Mufson MA, Musher DM, Spika JS, Breiman RF, Broome CV.

Arch Intern Med. 1994 Nov 28;154(22):2531-5. No abstract available.

PMID:
7979849
38.

Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination.

Musher DM, Groover JE, Rowland JM, Watson DA, Struewing JB, Baughn RE, Mufson MA.

Clin Infect Dis. 1993 Jul;17(1):66-73.

PMID:
8353248
39.

United we stand.

Glickman RM, Bennett JC, Nolan JP, Stobo JD, Rubenstein AH, Mufson MA, Terwilliger J.

Ann Intern Med. 1993 Jun 1;118(11):903-4. No abstract available.

PMID:
8480967
40.
41.
42.

Shedding of infectious virus and virus antigen during acute infection with respiratory syncytial virus.

Waris M, Meurman O, Mufson MA, Ruuskanen O, Halonen P.

J Med Virol. 1992 Oct;38(2):111-6.

PMID:
1460457
43.

Identification of subgroups of bovine respiratory syncytial virus.

Baker JC, Wilson EG, McKay GL, Stanek RJ, Underwood WJ, Velicer LF, Mufson MA.

J Clin Microbiol. 1992 May;30(5):1120-6.

44.

Distinguishing between respiratory syncytial virus subgroups by protein profile analysis.

Walpita P, Mufson MA, Stanek RJ, Pfeifer D, Connor JD.

J Clin Microbiol. 1992 Apr;30(4):1030-2.

45.

Characteristics and outcome variables of HIV cases at a university-based medical practice.

Zarraga AL, Hernandez J, Mufson MA.

W V Med J. 1992 Feb;88(2):46-9.

PMID:
1557906
46.

Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses.

Sullender WM, Mufson MA, Anderson LJ, Wertz GW.

J Virol. 1991 Oct;65(10):5425-34.

47.

Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination.

Mufson MA, Hughey DF, Turner CE, Schiffman G.

Vaccine. 1991 Jun;9(6):403-7.

PMID:
1887670
48.

A single-season epidemic with respiratory syncytial virus subgroup B2 during 10 epidemic years, 1978 to 1988.

Mufson MA, Akerlind-Stopner B, Orvell C, Belshe RB, Norrby E.

J Clin Microbiol. 1991 Jan;29(1):162-5.

49.

A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop.

Akerlind-Stopner B, Utter G, Mufson MA, Orvell C, Lerner RA, Norrby E.

J Virol. 1990 Oct;64(10):5143-8.

50.

Supplemental Content

Loading ...
Support Center